According to our (Global Info Research) latest study, the global Cryotherapy Ablation Device for Tumor Treatment market size was valued at US$ 570 million in 2025 and is forecast to a readjusted size of US$ 2643 million by 2032 with a CAGR of 24.8% during review period.
In 2025, global sales of cryoablation devices for tumor treatment reached 806 units, with an average price of $687,000 per unit.
Cryoablation refers to a method of freezing diseased tissue through low-temperature technology to achieve in situ inactivation of solid tissue. The working principle is to use low temperature to quickly cool down the diseased tissue to destroy cells, causing cell necrosis or apoptosis, thereby achieving the purpose of treatment. Since cryoablation uses the physical method of energy exchange to achieve the purpose of treatment, its trauma and side effects to the human body are much lower than conventional radiotherapy and chemotherapy, so it is hailed as a "green therapy".
The raw materials for tumor cryoablation devices fall into two main categories: materials for the main unit and materials for disposable consumables. Regarding the main unit, core components include a high-precision gas control system (comprising pressure sensors, flow control valves, and solenoid valves), a touchscreen display and control system, vacuum-insulated gas lines, an aluminum alloy or stainless steel chassis frame, and a power management system. These components demand extremely high standards of precision manufacturing and electronic component quality; furthermore, due to regulatory requirements (such as FDA, CE, and NMPA), manufacturers often rely on single-source strategies for critical parts, making supply chain substitution difficult. As the core consumable, the cryoablation needle utilizes the following materials: needle tip material (Inconel 625 nickel-chromium alloy for MRI-compatible versions, or AISI 316L stainless steel for non-MRI-compatible versions); handle material (copper, insulated with heat-shrink tubing); catheter material (polyurethane); and connector material (polyoxymethylene/POM). Additionally, materials are required for vacuum insulation layers, welding solder (for vacuum exhaust sealing), and sterile packaging. The gas supply system relies on high-pressure argon and helium cylinders, along with associated high-pressure piping and pressure-reducing valves.
In terms of cost structure, cryoablation devices exhibit the characteristics of a classic "razor-and-blade" business model. Although the main unit commands a high price (hundreds of thousands of dollars), profits are primarily derived from high-margin disposable consumables (the cryoablation needles). Taking a disposable cryoablation needle as an example, the retail price ranges from approximately RMB 8,000 to 18,800 per unit or higher, whereas raw material costs (stainless steel/nickel-chromium alloy needle shafts, polyurethane catheters, polyoxymethylene connectors, vacuum insulation materials, etc.) account for only 10–20% of the price. Key cost drivers include: ① Precision manufacturing processes—the probe requires a vacuum insulation layer structure, involving complex procedures such as vacuum exhaust welding and stepped-hole sealing, which demand extremely high machining precision; ② Sterile production environment—assembly and packaging must be carried out in cleanrooms; ③ Regulatory compliance costs—significant investment is required for the registration, clinical validation, and quality system establishment of Class III medical devices; and ④ R&D amortization—investments in developing novel phase-change refrigeration technology, intelligent temperature control algorithms, and imaging integration systems must be recouped through the sale of consumables. Costs for the main console unit are primarily concentrated in the electronic control system (approx. 30–40%), precision gas piping (approx. 20–25%), chassis structure (approx. 10–15%), and software system (approx. 15–20%). Notably, supply chain risk is high due to the reliance on single-source suppliers for key raw materials and components; any upstream capacity constraints or quality issues directly impact the production of the complete unit and clinical supply.
This report is a detailed and comprehensive analysis for global Cryotherapy Ablation Device for Tumor Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cryotherapy Ablation Device for Tumor Treatment market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Cryotherapy Ablation Device for Tumor Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Cryotherapy Ablation Device for Tumor Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Cryotherapy Ablation Device for Tumor Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cryotherapy Ablation Device for Tumor Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cryotherapy Ablation Device for Tumor Treatment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Icecure Medical (IL), Boston Scientific (US), Metrum Cryoflex (PL), Siemens (DE), Hygea Beijing (CN), AccuTarget MediPharma (CN), STERIS (US), ERBE Elektromedizin (DE), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cryotherapy Ablation Device for Tumor Treatment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Phase Change Refrigeration
Joule-Thomson Throttling Refrigeration
Market segment by Probe Diameter
1.3-1.5mm
1.7mm
2.4-3.5mm
Market segment by Treatment Method
Percutaneous Puncture
Laparoscopic/Endoscopic
Market segment by Application
Kidney Cancer
Lung Cancer
Prostate Cancer
Liver Cancer
Breast Cancer
Others
Major players covered
Icecure Medical (IL)
Boston Scientific (US)
Metrum Cryoflex (PL)
Siemens (DE)
Hygea Beijing (CN)
AccuTarget MediPharma (CN)
STERIS (US)
ERBE Elektromedizin (DE)
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cryotherapy Ablation Device for Tumor Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cryotherapy Ablation Device for Tumor Treatment, with price, sales quantity, revenue, and global market share of Cryotherapy Ablation Device for Tumor Treatment from 2021 to 2026.
Chapter 3, the Cryotherapy Ablation Device for Tumor Treatment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cryotherapy Ablation Device for Tumor Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Cryotherapy Ablation Device for Tumor Treatment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cryotherapy Ablation Device for Tumor Treatment.
Chapter 14 and 15, to describe Cryotherapy Ablation Device for Tumor Treatment sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Cryotherapy Ablation Device for Tumor Treatment. Industry analysis & Market Report on Cryotherapy Ablation Device for Tumor Treatment is a syndicated market report, published as Global Cryotherapy Ablation Device for Tumor Treatment Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Cryotherapy Ablation Device for Tumor Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.